GlassScriptPhysician profile
Pablo Vladimir Marrero
NPI 1255397097
$2,338.17
in general payments reported to CMS, 2019-2025
13 companies · $164 in 2025
The $164 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,293 · 2020: $86.08 · 2021: $384 · 2022: $44.11 · 2023: $287 · 2024: $80.09 · 2025: $164.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $531.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $530.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $464.78 | 2019-2025 | Mako |
| Biomarin Pharmaceutical INC. | $372.75 | 2019-2021 | |
| Smith+Nephew, INC. | $249.07 | 2021-2023 | Evos, Evos Mini |
| Boston Scientific Corporation | $241.13 | 2021-2023 | |
| Johnson and Johnson International | $240.71 | 2019-2022 | |
| Medtronic USA, INC. | $191.58 | 2019 | |
| Nuvasive, INC. | $131.02 | 2019-2023 | Reline |
| Ferring Pharmaceuticals INC. | $122.16 | 2019 | |
| Glaxosmithkline, LLC. | $97.09 | 2019 | |
| Alphatec Spine, INC | $80.09 | 2024 | Invictus Open |
| Medtronic, INC. | $78.43 | 2021 | |
| Medicrea USA, Corp. | $45.35 | 2019 | |
| Zimmer Biomet Holdings, INC. | $24.01 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pablo Marrero listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.